Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06386354 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Residual Neuromuscular Block in the Post-Anesthetic Unit and Postoperative Complications

Study acronym: Porcerito
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 24, 2025 (before its estimated October 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment target: 100 to 296
    • Primary and study completion dates: Oct 30, 2024 to Oct 30, 2025
    • Study description expanded, about 46 words
    v4
  2. Primary and study completion dates: Jul 30, 2024 to Oct 30, 2024v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 1 to 2
    • Primary and study completion dates: Jun 30, 2024 to Jul 30, 2024
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The use of neuromuscular blockers (NMB) is essential to optimize surgical conditions, ensure patient immobility during the intervention and prevent complications derived from involuntary movements. Intraoperative monitoring of neuromuscular relaxation allows the depth of neuromuscular blockade to be accurately evaluated, guaranteeing ideal conditions for the surgical team. Residual neuromuscular blockade (RNMB) is the persistence of muscle paralysis after the administration of NMB during a surgical intervention. The appearance of RNMB poses substantial challenges in the postoperative period, as it has negative repercussions for the safety and well-being of the patient.
Trial Details
NCT Number NCT06386354
Lead Sponsor Hospital Universitario de Gran Canaria Doctor Negrín
Conditions
(from sponsor)		 Postoperative Neuromuscular Block, Postoperative Complications
Related terms Postoperative Complications
Enrollment 296 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov